Homepage | Set Home | Add to Favorites
Member

Shanghai TheraMabs Bio-Technology Co.,Ltd


Search
 

Friends links

Browse by Showcase | Browse by List Products
Picture Heading Updated
Alirocumab
This product is the biosimilar of Alirocumab (1245916-14-6), which is a human monoclonal antibody that targets proprotein convertase subtilisin kexin type 9 (PCSK9). It is a PCSK9 inhibitor produced by recombinant DNA technology in Chinese Hamster Ovary c
2018-12-28
Atezolizumab
This product is the biosimilar of Atezolizumab (1380723-44-3), which is an Fc-engineered, humanized, monoclonal antibody that binds to PD-L1 and blocks interactions with the PD-1 and B7.1 receptors. the biosimilar is a non-glycosylated IgG1 kappa immunogl
2018-12-22
Alemtuzumab
Our product is the biosimilar of Alemtuzumab (216503-57-0), which is a recombinant DNA-derived humanized monoclonal antibody (Campath-1H) directed against the 21-28 kDa cell surface glycoprotein, CD52. It is an IgG1 kappa antibody with human variable fram
2018-12-16
Adalimumab
Product Name:Adalimumab Introduction: Our product is the biosimilar of Adalimumab (331731-18-1), which is recombinant human IgG1 monoclonal antibody specific for human tumor necrosis factor with human derived heavy and light chain variable regions and hum
2018-11-16
Avelumab
This product is the biosimilar of Avelumab (1537032-82-8), which is a programmed death ligand-1 (PD-L1) blocking antibody. The biosimilar is a human IgG1 lambda monoclonal antibody that has a molecular weight of approximately 147 kDa, which is produced by
2018-07-27
   Home   Next   Previous   Last